Business
BetterLife Pharma Appoints Corporate Advisor
VANCOUVER, British Columbia, April 03, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, has announced that it has appointed André Beaudry as Corporate Advisor. Mr. Beaudry has over 30 years of experience in the areas of fundraising, government relations, national and international program management, as well as governance. Mr. Beaudry has led teams in Canada, China, England, India and the Philipp
About this update from Betterlife Pharma Inc.
[{"type":"image","alt":"BetterLife Pharma Inc.","displaySize":"","headline":null,"caption":"BetterLife Pharma Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":286,"height":79,"url":"https://media.zenfs.com/en/globenewswire.com/8ec617ad108ee4b453638b3289aecdcf"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.eZRgbrXhIvBBD2d8LUGaA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExNjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/8ec617ad108ee4b453638b3289aecdcf","width":286,"height":79}},"lazy":false},{"type":"text","content":"VANCOUVER, British Columbia, April 03, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, has announced that it has appointed André Beaudry as Corporate Advisor. Mr. Beaudry has over 30 years of experience in the areas of fundraising, government relations, national and international program management, as well as governance.","length":425,"tagName":"p"},{"type":"text","content":"Mr. Beaudry has led teams in Canada, China, England, India and the Philippines, and collaborated with industry, education, government and philanthropic leaders to secure over $140M for a variety of initiatives, including mental health. As Founder of Velocity Collaboration Corporation, he is consistently focused on the possibility of what an organization can become, which he accomplishes through his work as a strategic advisor on business and philanthropic mandates.","length":469,"tagName":"p"},{"type":"text","content":"Mr. Beaudry commented, “I’m an ardent supporter and shareholder of BetterLife, and having worked with many PhD’s, I have great respect for their scientists and academic advisors. In only 4 years they’ve developed and extensively tested their patented non-hallucinogenic compound (BETR-001), which has been proven to renew the neural circuits of the brain when affected by chronic stress or trauma. I’m looking forward to collaborating with management and board to bring BETR-001 to human clinical trials. The motivation is to help millions of people, globally, lead healthier lives, now that it has successfully and safely completed the majority of its FDA required IND-enabling studies. I believe we’re just at the beginning of seeing the potential of this therapy as a safe, accessible, and patient-friendly solution to address ...